DOI QR코드

DOI QR Code

Clinical Manifestations of Invasive Infections due to Streptococcus pyogenes in Children

소아에서 발생한 A군 연쇄구균에 의한 침습성 질환의 임상적 특성 분석

  • Yang, Nuri (Department of Pediatrics, Seoul National University Children's Hospital) ;
  • Lee, Hyeon Seung (Department of Pediatrics, Seoul National University Children's Hospital) ;
  • Choi, Jae Hong (Department of Pediatrics, Seoul National University Children's Hospital) ;
  • Cho, Eun Young (Department of Pediatrics, Seoul National University Children's Hospital) ;
  • Choi, Eun Hwa (Department of Pediatrics, Seoul National University Children's Hospital) ;
  • Lee, Hoan Jong (Department of Pediatrics, Seoul National University Children's Hospital) ;
  • Lee, Hyunju (Department of Pediatrics, Seoul National University Bundang Hospital)
  • 양누리 (서울대학교 어린이병원 소아청소년과) ;
  • 이현승 (서울대학교 어린이병원 소아청소년과) ;
  • 최재홍 (서울대학교 어린이병원 소아청소년과) ;
  • 조은영 (서울대학교 어린이병원 소아청소년과) ;
  • 최은화 (서울대학교 어린이병원 소아청소년과) ;
  • 이환종 (서울대학교 어린이병원 소아청소년과) ;
  • 이현주 (분당 서울대학교병원 소아청소년과)
  • Received : 2014.04.19
  • Accepted : 2014.05.15
  • Published : 2014.08.25

Abstract

Purpose: Streptococcus pyogenes is an important cause of invasive diseases in children. We aimed to describe the clinical characteristics of invasive infections due to S. pyogenes in children in Korea. Methods: A retrospective study of children under 18 years of age with invasive infections due to S. pyogenes at Seoul National University Children's Hospital between March 1992 and December 2012, and Seoul National University Bundang Hospital between March 2003 and December 2012 was conducted. Demographic factors, clinical characteristics, laboratory findings, treatment, mortality and morbidity of all patients were reviewed. Results: A total of 30 among 36 cases identified as invasive disease due to S. pyogenes were available for review. There was a predominance for male subjects (male:female=2.75:1). The median age was 50 months (range 12 days to 15 years) and 53.3% were under 5 years of age. Skin and soft tissue infections (9/30, 30.0%), bacteremia without identified focus (4/30, 13.3%) and bone and joint infections (6/30, 20.0%) were the most frequent clinical presentations. Streptococcal toxic shock syndrome (3/30, 10.0%) pulmonary, abdomen and central nervous system infections (2/30, 6.7%) were also seen. There was a peak in number of patients in year 2012 (9/30, 30.0%). There were no cases of mortality. Erythromycin and clindamycin resistance rates were low by 3.8% and 7.5%, respectively. Conclusion: We studied the clinical presentations of invasive infections due to S. pyogenes during the past 20 years in Korean children. The findings of this study help us understand the characteristics of the disease, enhancing early recognition and prompting adequate antibiotic therapy which is important in reducing morbidity and mortality.

목적: A군 연쇄구균은 소아에서 인두염, 연조직염을 일으키며 드물게 침습성 질환을 일으키는 중요한 원인균이다. 그리하여 본 연구에서는 한국 소아에서 A군 연쇄구균 침습성 감염증의 임상 양상 및 예후에 대해 조사하고자 하였다. 방법: 1992년 3월부터 2012년 12월까지 서울대학교 어린이병원 및 2003년 3월부터 2012년 12월까지 분당 서울대학교병원에 입원한 환자 중 A군 연쇄구균 침습성 감염증으로 치료받은 18세 이하의 소아를 대상으로 하였다. 의무기록을 후향적으로 분석하여 대상환자들의 임상양상, 검사결과, 치료방법 및 예후와 합병증에 대해 조사하였다. 결과: A군 연쇄구균 침습성 감염증으로 진단 받은 총 36명의 환자 중 30명에 대해 의무기록을 확인할 수 있었다. 남자가 많았으며(남:여=2.75:1) 환자들의 중앙연령은 4년 2개월(생후 12일부터 15세까지)로 그 중 53.3%가 5세 미만이었다. 질환은 피부 및 연조직감염증(9/30, 30.0%), 국소 감염부위가 없는 균혈증(4/30, 13.3%) 그리고 관절염 및 골수염(6/30, 20.0%)가 가장 많은 것으로 확인되었다. 연쇄구균 독소쇼크증후군(3/30, 10.0%), 호흡기, 복부 및 중추신경계 감염증도 확인되었다. 전체기간 중 2012년에 환자발생이 가장 많았으며(9/30, 30.0%), 사망한 사례는 없었다. Erythromycin 및 clindamycin에 대한 항생제 내성률은 각각 3.8% 및 7.5%로 확인되었다. 결론: 본 연구를 통해 소아에서 A군 연쇄구균 침습성 감염증으로 입원치료 받은 환자들의 임상양상을 확인할 수 있었으며 주로 5세 미만의 어린 연령층에서 발생하는 것을 알 수 있었다. 지난 20년 동안 한국 소아에서 발생한 A군 연쇄구균 침습성 감염증의 임상적 특성 및 예후를 조사함으로써 향후 임상에서 환자를 빠르게 인지하고 적절하게 치료하는데 본 연구결과가 도움이 될 수 있을 것으로 생각된다.

Keywords

References

  1. World Health Organization. The current evidence for the burden of group A streptococcal diseases. 2005.
  2. Meehan M, Murchan S, Bergin S, O’Flanagan D, Cunney R. Increased incidence of invasive group A streptococcal disease in Ireland, 2012 to 2013. Euro Surveill 2013;18:20556.
  3. Health Protection Report, 2013. Group A streptococcal infections: update on seasonal activity 2012/2013. Available from: http://www.hpa.org.uk/hpr/archives/2013/news1713.htm.
  4. Darenberg J, Henriques-Normark B, Lepp T, Tegmark- Wisell K, Tegnell A, Widgren K. Increased incidence of invasive group A streptococcal infections in Sweden, January 2012-February 2013. Euro Surveill 2013;18:20443. https://doi.org/10.2807/1560-7917.ES2013.18.14.20443
  5. Stockmann C, Ampofo K, Hersh AL, Blaschke AJ, Kendall BA, Korgenski K, et al. Evolving epidemiologic characteristics of invasive group a streptococcal disease in Utah, 2002-2010. Clin Infect Dis 2012;55:479-87. https://doi.org/10.1093/cid/cis422
  6. Lamagni TL, Darenberg J, Luca-Harari B, Siljander T, Efstratiou A, Henriques-Normark B, et al. Epidemiology of severe Streptococcus pyogenes disease in Europe. J Clin Microbiol 2008;46:2359-67. https://doi.org/10.1128/JCM.00422-08
  7. Minodier P, Bidet P, Rallu F, Tapiero B, Bingen E, Ovetchkine P. Clinical and microbiologic characteristics of group A streptococcal necrotizing fasciitis in children. Pediatr Infect Dis J 2009;28:541-3. https://doi.org/10.1097/INF.0b013e318195bb10
  8. Lepoutre A, Doloy A, Bidet P, Leblond A, Perrocheau A, Bingen E, et al. Epidemiology of invasive Streptococcus pyogenes infections in France in 2007. J Clin Microbiol 2011;49:4094-5100. https://doi.org/10.1128/JCM.00070-11
  9. Lee JH, Cho HK, Kim KH, Kim CH, Kim DS, Kim KN, et al. Etiology of invasive bacterial infections in immunocompetent children in Korea (1996-2005): a retrospective multicenter study. J Korean Med Sci 2011;26:174-83. https://doi.org/10.3346/jkms.2011.26.2.174
  10. Cho EY, Kim YJ, Eun BW, Kim YK, Cho DS, Lee HS, et al. Causative pathogens among childhood bacterial invasive infection in Korea; a multicenter study, 2006-2010. In: The 2012 Annual Meeting of the Korean Society of Pediatric Infectious Diseases; 2012 Nov 10; Seoul, Korea.
  11. Cho EY, Choi EH, Lee H, Kang JH, Kim KH, Lee HJ, et al. Multicentric approach for analysis of serotypes of pneumococcus isolated from invasive infections in Korean children. Korea. In: The 2013 Annual Meeting of the Korean Society of Pediatric Infectious Diseases; 2013 Nov 9; Seoul, Korea.
  12. Rodriguez-Nunez A, Dosil-Gallardo S, Jordan I. ad hoc Streptococcal toxic shock syndrome collaborative group of Spanish society of pediatric intensive care. Clinical characteristics of children with group A streptococcal toxic shock syndrome admitted to pediatric intensive care units. Eur J Pediatr 2011;170:639-44. https://doi.org/10.1007/s00431-010-1337-x
  13. McMillan DJ, Dreze PA, Vu T, Bessen DE, Guglielmini J, Steer AC. Updated model of group A streptococcus M proteins based on a comprehensive worldwide study. Clin Microbiol Infect 2013;19:E222-9. https://doi.org/10.1111/1469-0691.12134
  14. Martin DR, Single LA. Molecular epidemiology of group A streptococcus M type 1 infections. J Infect Dis 1993;167:1112-7. https://doi.org/10.1093/infdis/167.5.1112
  15. O'Loughlin RE, Roberson A, Cieslak PR, Lynfield R, Gershman K, Craig A, et al. The epidemiology of invasive group A streptococcal infection and potential vaccine implications: United States, 2000-2004. Clin Infect Dis 2007;45:853-62. https://doi.org/10.1086/521264
  16. Tyrrell GJ, Lovgren M, Kress B, Grimsrud K. Invasive group A streptococcal disease in Alberta, Canada (2000 to 2002). J Clin Microbiol 2005;43:1678-83. https://doi.org/10.1128/JCM.43.4.1678-1683.2005
  17. Kim SH. Epidemiology and erythromycin resistance of Streptococcus pyogenes in the last 20 years. Korean J Clin Microbiol 2011;14:119-125. https://doi.org/10.5145/KJCM.2011.14.4.119
  18. Fujita K, Murono K, Yoshikawa M, Murai T. Decline of erythromycin resistance of group A streptococci in Japan. Pediatr Infect Dis J 1994;13:1075-8. https://doi.org/10.1097/00006454-199412000-00001
  19. Bass JW, Weisse ME, Plymyer MR, Murphy S, Eberly BJ. Decline of erythromycin resistance of group A betahemolytic streptococci in Japan. Comparison with worldwide reports. Arch Pediatr Adolesc Med 1994;148:67-71. https://doi.org/10.1001/archpedi.1994.02170010069016
  20. Bergman M, Huikko S, Pihlajamäki M, Laippala P, Palva E, Huovinen P, et al; Finnish Study Group for Antimicrobial Resistance (FiRe Network). Effect of macrolide consumption on erythromycin resistance in Streptococcus pyogenes in Finland in 1997-2001.Clin Infect Dis 2004;38:1251-6. https://doi.org/10.1086/383309
  21. Koh E, Kim S. Decline in erythromycin resistance in group A streptococci from acute pharyngitis due to changes in the emm genotypes rather than restriction of antibiotic use. Korean J Lab Med 2010;30:485-90. https://doi.org/10.3343/kjlm.2010.30.5.485
  22. Oliver MA, García-Delafuente C, Cano ME, Perez-Hernandez F, Martinez-Martinez L, Alberti S. Rapid decrease in the prevalence of macrolide-resistant group A streptococci due to the appearance of two epidemic clones in Cantabria (Spain). J Antimicrob Chemother 2007;60:450-2. https://doi.org/10.1093/jac/dkm174
  23. American Academy of Pediatrics. Committee on Infectious Diseases. Severe invasive group A streptococcal infections: a subject review. Pediatrics 1998;101:136-40. https://doi.org/10.1542/peds.101.1.136
  24. Wilson GJ, Talkington DF, Gruber W, Edwards K, Dermody TS. Group A streptococcal necrotizing fasciitis following varicella in children: case reports and review. Clin Infect Dis 1995;20:1333-8. https://doi.org/10.1093/clinids/20.5.1333
  25. Doctor A, Harper MB, Fleisher GR. Group A betahemolytic streptococcal bacteremia: historical overview, changing incidence, and recent association with varicella. Pediatrics 1995;96:428-33.
  26. Factor SH, Levine OS, Harrison LH, Farley MM, McGeer A, Skoff T, et al. Risk factors for pediatric invasive group A streptococcal disease. Emerg Infect Dis 2005;11:1062-6. https://doi.org/10.3201/eid1107.040900

Cited by

  1. 소아환자에서의 A군 사슬알균 혈류감염: 단일기관 연구 vol.27, pp.2, 2014, https://doi.org/10.14776/piv.2020.27.e15